N-(INDOLCARBONYL)PIPERAZINE DERIVATIVES, METHODS FOR PRODUCTION THE SAME, PHARMACEUTICAL COMPOSITION, AND COMPOUNDS

FIELD: organic chemistry, pharmaceutical compositions. ^ SUBSTANCE: invention relates to N-(indolcarbonyl)piperazine derivatives of general formula I ^ , wherein R1 is optionally substituted phenyl or naphthyl; R2 and R3 are independently Hal or Het1, A, OA, CN; R4 is H, CN, acyl, Hal, CONH2, CONHA...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KHARTING JURGEN, ZEJFRID KRISTOF, GRAJNER KHARTMUT, VAN-AMSTERDAM KRISTOF, BETTKHER KHENNING, BARTOSHIK GERD
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator KHARTING JURGEN
ZEJFRID KRISTOF
GRAJNER KHARTMUT
VAN-AMSTERDAM KRISTOF
BETTKHER KHENNING
BARTOSHIK GERD
description FIELD: organic chemistry, pharmaceutical compositions. ^ SUBSTANCE: invention relates to N-(indolcarbonyl)piperazine derivatives of general formula I ^ , wherein R1 is optionally substituted phenyl or naphthyl; R2 and R3 are independently Hal or Het1, A, OA, CN; R4 is H, CN, acyl, Hal, CONH2, CONHA or CONA; R1 is H; or R4 and R5 together form C3-C5-group; Het1 is aromatic heterocyclic ring, optionally substituted with one or two halogen atoms and containing 1-3 similar or different heteroatoms such as nitrogen, sulfur and oxygen, A-(C1-C6)-alkyl; Hal is F, Cl,Br, and J; and indole ring may be substituted with isatin, except for (1H-indole-5-yl)-(4-phenethylpiperazine-1-yl)-methanone and 1-((5-methoxy-1H-indole-7-yl)-carbonyl)-4-(2-phenethyl)-piperazine. Claimed compounds are potent 5-HT2A antagonists and are useful in treatment of psychosis, schizophrenia, depression, neurological diseases, dismepodia, Parlinson's disease, Alzheimer's disease, Hungtington's disease, amyotrophic lateral sclerosis, bulimia or anorexia, premenstrual syndrome, and/or in alleviation of hypomania. ^ EFFECT: new pharmaceutical agents. ^ 9 cl, 10 ex, 1 tbl
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2251548C2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2251548C2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2251548C23</originalsourceid><addsrcrecordid>eNqNyr0KwjAUQOEuDqK-wx0V2sFqwfWaXEmgyQ35KehSisRJtFDfHxF9AKcDh29eTLZaayu5FeiPbM_txmlHHi_aEkjyusOoOwolGIqKZYATe3CeZRJRs4WoCAIaKsEp9AYFpagFtiDYOA76g0pAK78jWRmWxew23Ke8-nVRwImiUFUen32exuGaH_nV-1TXzbbZH0S9-4O8ATr8OKo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>N-(INDOLCARBONYL)PIPERAZINE DERIVATIVES, METHODS FOR PRODUCTION THE SAME, PHARMACEUTICAL COMPOSITION, AND COMPOUNDS</title><source>esp@cenet</source><creator>KHARTING JURGEN ; ZEJFRID KRISTOF ; GRAJNER KHARTMUT ; VAN-AMSTERDAM KRISTOF ; BETTKHER KHENNING ; BARTOSHIK GERD</creator><creatorcontrib>KHARTING JURGEN ; ZEJFRID KRISTOF ; GRAJNER KHARTMUT ; VAN-AMSTERDAM KRISTOF ; BETTKHER KHENNING ; BARTOSHIK GERD</creatorcontrib><description>FIELD: organic chemistry, pharmaceutical compositions. ^ SUBSTANCE: invention relates to N-(indolcarbonyl)piperazine derivatives of general formula I ^ , wherein R1 is optionally substituted phenyl or naphthyl; R2 and R3 are independently Hal or Het1, A, OA, CN; R4 is H, CN, acyl, Hal, CONH2, CONHA or CONA; R1 is H; or R4 and R5 together form C3-C5-group; Het1 is aromatic heterocyclic ring, optionally substituted with one or two halogen atoms and containing 1-3 similar or different heteroatoms such as nitrogen, sulfur and oxygen, A-(C1-C6)-alkyl; Hal is F, Cl,Br, and J; and indole ring may be substituted with isatin, except for (1H-indole-5-yl)-(4-phenethylpiperazine-1-yl)-methanone and 1-((5-methoxy-1H-indole-7-yl)-carbonyl)-4-(2-phenethyl)-piperazine. Claimed compounds are potent 5-HT2A antagonists and are useful in treatment of psychosis, schizophrenia, depression, neurological diseases, dismepodia, Parlinson's disease, Alzheimer's disease, Hungtington's disease, amyotrophic lateral sclerosis, bulimia or anorexia, premenstrual syndrome, and/or in alleviation of hypomania. ^ EFFECT: new pharmaceutical agents. ^ 9 cl, 10 ex, 1 tbl</description><edition>7</edition><language>eng ; rus</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2005</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20050510&amp;DB=EPODOC&amp;CC=RU&amp;NR=2251548C2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20050510&amp;DB=EPODOC&amp;CC=RU&amp;NR=2251548C2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KHARTING JURGEN</creatorcontrib><creatorcontrib>ZEJFRID KRISTOF</creatorcontrib><creatorcontrib>GRAJNER KHARTMUT</creatorcontrib><creatorcontrib>VAN-AMSTERDAM KRISTOF</creatorcontrib><creatorcontrib>BETTKHER KHENNING</creatorcontrib><creatorcontrib>BARTOSHIK GERD</creatorcontrib><title>N-(INDOLCARBONYL)PIPERAZINE DERIVATIVES, METHODS FOR PRODUCTION THE SAME, PHARMACEUTICAL COMPOSITION, AND COMPOUNDS</title><description>FIELD: organic chemistry, pharmaceutical compositions. ^ SUBSTANCE: invention relates to N-(indolcarbonyl)piperazine derivatives of general formula I ^ , wherein R1 is optionally substituted phenyl or naphthyl; R2 and R3 are independently Hal or Het1, A, OA, CN; R4 is H, CN, acyl, Hal, CONH2, CONHA or CONA; R1 is H; or R4 and R5 together form C3-C5-group; Het1 is aromatic heterocyclic ring, optionally substituted with one or two halogen atoms and containing 1-3 similar or different heteroatoms such as nitrogen, sulfur and oxygen, A-(C1-C6)-alkyl; Hal is F, Cl,Br, and J; and indole ring may be substituted with isatin, except for (1H-indole-5-yl)-(4-phenethylpiperazine-1-yl)-methanone and 1-((5-methoxy-1H-indole-7-yl)-carbonyl)-4-(2-phenethyl)-piperazine. Claimed compounds are potent 5-HT2A antagonists and are useful in treatment of psychosis, schizophrenia, depression, neurological diseases, dismepodia, Parlinson's disease, Alzheimer's disease, Hungtington's disease, amyotrophic lateral sclerosis, bulimia or anorexia, premenstrual syndrome, and/or in alleviation of hypomania. ^ EFFECT: new pharmaceutical agents. ^ 9 cl, 10 ex, 1 tbl</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2005</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyr0KwjAUQOEuDqK-wx0V2sFqwfWaXEmgyQ35KehSisRJtFDfHxF9AKcDh29eTLZaayu5FeiPbM_txmlHHi_aEkjyusOoOwolGIqKZYATe3CeZRJRs4WoCAIaKsEp9AYFpagFtiDYOA76g0pAK78jWRmWxew23Ke8-nVRwImiUFUen32exuGaH_nV-1TXzbbZH0S9-4O8ATr8OKo</recordid><startdate>20050510</startdate><enddate>20050510</enddate><creator>KHARTING JURGEN</creator><creator>ZEJFRID KRISTOF</creator><creator>GRAJNER KHARTMUT</creator><creator>VAN-AMSTERDAM KRISTOF</creator><creator>BETTKHER KHENNING</creator><creator>BARTOSHIK GERD</creator><scope>EVB</scope></search><sort><creationdate>20050510</creationdate><title>N-(INDOLCARBONYL)PIPERAZINE DERIVATIVES, METHODS FOR PRODUCTION THE SAME, PHARMACEUTICAL COMPOSITION, AND COMPOUNDS</title><author>KHARTING JURGEN ; ZEJFRID KRISTOF ; GRAJNER KHARTMUT ; VAN-AMSTERDAM KRISTOF ; BETTKHER KHENNING ; BARTOSHIK GERD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2251548C23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; rus</language><creationdate>2005</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KHARTING JURGEN</creatorcontrib><creatorcontrib>ZEJFRID KRISTOF</creatorcontrib><creatorcontrib>GRAJNER KHARTMUT</creatorcontrib><creatorcontrib>VAN-AMSTERDAM KRISTOF</creatorcontrib><creatorcontrib>BETTKHER KHENNING</creatorcontrib><creatorcontrib>BARTOSHIK GERD</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KHARTING JURGEN</au><au>ZEJFRID KRISTOF</au><au>GRAJNER KHARTMUT</au><au>VAN-AMSTERDAM KRISTOF</au><au>BETTKHER KHENNING</au><au>BARTOSHIK GERD</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>N-(INDOLCARBONYL)PIPERAZINE DERIVATIVES, METHODS FOR PRODUCTION THE SAME, PHARMACEUTICAL COMPOSITION, AND COMPOUNDS</title><date>2005-05-10</date><risdate>2005</risdate><abstract>FIELD: organic chemistry, pharmaceutical compositions. ^ SUBSTANCE: invention relates to N-(indolcarbonyl)piperazine derivatives of general formula I ^ , wherein R1 is optionally substituted phenyl or naphthyl; R2 and R3 are independently Hal or Het1, A, OA, CN; R4 is H, CN, acyl, Hal, CONH2, CONHA or CONA; R1 is H; or R4 and R5 together form C3-C5-group; Het1 is aromatic heterocyclic ring, optionally substituted with one or two halogen atoms and containing 1-3 similar or different heteroatoms such as nitrogen, sulfur and oxygen, A-(C1-C6)-alkyl; Hal is F, Cl,Br, and J; and indole ring may be substituted with isatin, except for (1H-indole-5-yl)-(4-phenethylpiperazine-1-yl)-methanone and 1-((5-methoxy-1H-indole-7-yl)-carbonyl)-4-(2-phenethyl)-piperazine. Claimed compounds are potent 5-HT2A antagonists and are useful in treatment of psychosis, schizophrenia, depression, neurological diseases, dismepodia, Parlinson's disease, Alzheimer's disease, Hungtington's disease, amyotrophic lateral sclerosis, bulimia or anorexia, premenstrual syndrome, and/or in alleviation of hypomania. ^ EFFECT: new pharmaceutical agents. ^ 9 cl, 10 ex, 1 tbl</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; rus
recordid cdi_epo_espacenet_RU2251548C2
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title N-(INDOLCARBONYL)PIPERAZINE DERIVATIVES, METHODS FOR PRODUCTION THE SAME, PHARMACEUTICAL COMPOSITION, AND COMPOUNDS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T17%3A21%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KHARTING%20JURGEN&rft.date=2005-05-10&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2251548C2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true